Invivo recognized with 2010 Gold Medical Design Excellence Award

On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award (MDEA) for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.

Invivo's DynaTRIM is the first commercially available fully MRI-compatible interventional device for Trans-Rectal Interventional MRI of the prostate gland. A removable device, DynaTRIM is designed to affix to an MR imaging table with an open design that allows for flexibility in coil choice and a cleanable foam pad for extra patient comfort. Invivo's DynaCAD for Prostate solution provides physicians with a comprehensive, customizable set of advanced visualization tools for performing real-time analysis of prostate MRI studies.

The pairing of DynaCAD for Prostate with DynaTRIM then enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy. "The better the sample, the more uniformity in diagnosis and inter-observer variance," explains Dr. David B. Kaminsky of Palm Springs Pathology Services. "I have personally witnessed the calm reception of the patient during set-up and biopsy procedure which cultivates the patient's participation in navigating his illness and reduces anxiety to foster compliance with the technique," he adds.

Bernadette Greenwood, Prostate Product Manager at Invivo adds, "The synergistic integration of two commercially available technologies is demonstrated illustrating the potential for fast, safe, and effective minimally invasive MR-guided prostate intervention. We are honored to be recognized for our prostate MR analysis clinical solutions by the MDEA, the premier awards program for the medical technology community."

Source:

Invivo

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered MRI predicts outcomes in prostate cancer